ResMed Inc. (RMD)
NYSE · Healthcare
ResMed Inc. Shareholder Equity 2009–2025
ResMed Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- ResMed Inc. shareholder equity as of June 30, 2025: 5.97B, a 22.69% increase year-over-year.
- ResMed Inc. shareholder equity for 2025 were 5.97B, a 22.69% increase from 2024.
- ResMed Inc. shareholder equity for 2024 were 4.86B, a 17.78% increase from 2023.
- ResMed Inc. shareholder equity for 2023 were 4.13B, a 22.89% increase from 2022.
- ResMed Inc. shareholder equity for 2022 were 3.36B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| ResMed Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $5,968 |
| 2024 | $4,864 |
| 2023 | $4,130 |
| 2022 | $3,361 |
| 2021 | $2,886 |
| 2020 | $2,497 |
| 2019 | $2,072 |
| 2018 | $2,059 |
| 2017 | $1,960 |
| 2016 | $1,695 |
| 2015 | $1,587 |
| 2014 | $1,758 |
| 2013 | $1,611 |
| 2012 | $1,608 |
| 2011 | $1,731 |
ResMed Inc. Shareholder Equity — FAQ
ResMed Inc. (RMD) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RMD's shareholder equity history?
The chart and table above show ResMed Inc.'s shareholder equity by year and by quarter, including the growth rate.